CAPVAXIVE
Pneumococcal 21-valent conjugate (Pneu-C-21) · Pneumococcal
Health Canada DIN 02549891. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- CAPVAXIVE
- DIN
02549891- Vaccine
- Pneumococcal 21-valent conjugate (Pneu-C-21)
- Presentation
- 0.5 mL · solution · intramuscular · 18 years and older
- Live vaccine
- No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| Pneumococcal conjugate — adults 65 and older, one dose One dose of Pneu-C-20 or Pneu-C-21 for all adults 65 years and older. | 1 dose | All adults 65 years and older: one dose of Pneu-C-20 or Pneu-C-21 regardless of earlier pneumococcal vaccination, given at least 1 year after any previous Pneu-C-13, Pneu-C-15 or Pneu-P-23 dose (8 weeks in some circumstances). No further doses are currently recommended. |
| Pneumococcal conjugate — adults 18 to 64 with risk factors, one dose One dose of Pneu-C-20 or Pneu-C-21 for adults 18 to 64 with a condition that raises the risk of pneumococcal disease. | 1 dose | Adults 18 to 64 with immunocompromising conditions (HIV, asplenia, transplant, cancer, immunosuppressive therapy) or other risk factors for invasive pneumococcal disease (chronic heart, lung, kidney or liver disease, diabetes, alcohol use disorder, cochlear implant, CSF leak): one dose at least 8 weeks after any earlier pneumococcal vaccine. Stem-cell transplant recipients need a three-dose series plus booster instead. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Recommended for people at high risk of pneumococcal disease.
Family guidance on breastfeeding: Recommended for people at high risk of pneumococcal disease.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Pneumococcal vaccines: Canadian Immunization Guide — Chapter revised May 2024 · partial update July 2026
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365